Skip to content

Clinical analysis of Levosimendan associated arrhythmia in Heart Failure patients

Clinical analysis of Levosimendan associated arrhythmia in Heart Failure patients

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400091067
Enrollment
Unknown
Registered
2024-10-20
Start date
2024-10-21
Completion date
Unknown
Last updated
2024-10-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Heart failure

Interventions

Case series:None

Sponsors

Beijing Shijitan Hospital, Capital Medical University, Beijing
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Heart failure patients aged 18 or above; 2. Insufficient response to intravenous diuretics and/or vasodilators, manifested as dyspnea at rest or mechanical ventilation, and oliguria without hypovolemia; 3. Use levosimendan.

Exclusion criteria

Exclusion criteria: 1. AF before levosimendan therapy; 2. Ventricular tachycardia or ventricular fibrillation within the previous 2 weeks; 3. Treatment with other inotropic agents, such as dotamine, dobutamine, or milrinone, during hospitalization; 4. Heart failure due to hypertrophy, restrictive cardiomyopathy, or uncorrected stenotic valvular disease; 5. Systolic blood pressure =120 beats/min at rest; 7. Severe renal and hepatic insufficiency, acute respiratory distress syndrome, or septic shock.

Design outcomes

Primary

MeasureTime frame
Previous history of arrhythmia;Ejection fraction;Left ventricular size;Left atrial size on echocardiography;Atrial natriuretic peptide;Myocardial enzyme;Gender;Age;Heart rate;Blood creatinine;Transaminase;Blood potassium;

Secondary

MeasureTime frame
blood pressure;Blood fat;Past medication use;

Countries

China

Contacts

Public ContactTiecheng Yang

Emergency Department, Emergency and Critical Care Medical Center, Beijing Shijitan Hospital, Capital Medical University, Beijing

ytc3953@bjsjth.cn+86 185 1012 7716

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026